Rhea-AI Summary
Pharmagreen Biotech, Inc. (OTC PINKS: PHBI) has successfully exited Chapter 11 bankruptcy proceedings, initiated voluntarily on August 11, 2020. The company’s exit was confirmed following a lifted stay order by a U.S. District Judge on October 9, 2020, regarding EMA Financial LLC’s action. CEO Peter Wojcik stated the company is now focused on advancing its business plans. Pharmagreen specializes in developing tissue-cultured hemp plantlets, offering a proprietary process for producing genetically uniform, disease-free plantlets with high cannabinoid content.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-40.92%
Tags
FAQ
What is the current stock price of PHARMAGREEN BIOTECH (PHBI)?
The current stock price of PHARMAGREEN BIOTECH (PHBI) is $0.0005 as of August 11, 2026.
What is the market cap of PHARMAGREEN BIOTECH (PHBI)?
The market cap of PHARMAGREEN BIOTECH (PHBI) is approximately 570.7K.